When was CellCura founded?

CellCura was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Where is CellCura located?

CellCura is headquartered in Oslo, Norway.

How many employees does CellCura have?

As of Jul 01, 2024, the latest employee count at CellCura is 1 - 10.

Is CellCura a funded company?

CellCura is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 08, 2010.

When was the latest funding round of CellCura?

CellCura's latest funding was a $***** Grant (prize money) round on Jan 29, 2014, with participation from 1 investor.

Where does CellCura rank among its competitors?

CellCura ranks 383rd amongst 945 active competitors, of which 67 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of CellCura?

CellCura's top competitors include Abcam, BioLife Solutions and Meridian Bioscience. Among them, BioLamina secured the most recent funding round in April, 2026.

CellCura - 2026 Company Profile, Team, Funding & Competitors

Company Details

Cell Cura has developed protein free media for use in Assisted Reproductive Technology, and stem cell therapy. The product with no Bio-origin eliminates any risk of contamination. Also, the company claims, that protein free media is more stable and easy to manufacture. The company was founded in 2016 and is headquartered in Oslo, Norway.

Key Metrics

Founded Year

2005

Location

Oslo, Norway

Stage

Deadpooled

Latest Funding Round

Grant (prize money), Jan 29, 2014, $*****

Investors

Norwegian Research Council & 5 more

Ranked

383^rd among 945 active competitors

Employee Count

1 - 10 as on Jul 01, 2024

Similar Companies

Abcam & 1110 more

View CellCura's full profile

CellCura is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SOILCARE AS CIN: 980910059 , Norway, Active		-	-

CellCura has raised funding over 4 rounds. Its first funding round was on Mar 08, 2010. Its latest funding round was a Grant (prize money) round on Jan 29, 2014 for $*****. 1 investor participated in its latest round. CellCura has 6 institutional investors.

Here is the list of recent funding rounds of CellCura:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 29, 2014	1829364	Grant (prize money)	1243559	3313784	9982281	7711347
Jun 13, 2013	2506962	Post IPO	8160521	2430272	1184042	9266733
Dec 19, 2011	7886151	Post IPO	5213814	9915288	2229163	1437061

Access funding benchmarks and valuations. Sign up today!

View details of CellCura's funding rounds and investors

CellCura's employee count trend

CellCura has 1 - 10 employees as of Jul 24. Here is CellCura's employee count trend over the years:

Uncover CellCura's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CellCura include Abcam, BioLife Solutions and Meridian Bioscience. Here is the list of Top 10 competitors of CellCura, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
3rd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
4th	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
5th	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
8th	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	57/100
9th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
10th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
383rd	CellCura 2005, Oslo (Norway), Deadpooled	Cell Culture reagent provider	-	Norwegian Research Council, Alliant Energy ... & 4 others	26/100